Organizations like yours are familiar to us. We are chemists, engineers, molecular biologists, researchers, and scientists who combine our technical understanding with legal, regulatory, and compliance excellence to provide you with well-informed counsel – from your patent portfolio development, protection, and monetization strategies to market entry and exit strategies.
Whether you are an inventor, start-up, venture capitalist, investor, Fortune 50 or Fortune 500 company, or research institution we help people like you on all aspects of pharmaceuticals, biotechnology and medical devices. We understand that regulatory and compliance will dominate your thinking – and can help you meet your requirements on every issue from M&A to tax, HR and real estate.
We know that often in this industry, time is of the essence, and we are proud that we continually demonstrate that we can work at speed without compromising on efficiency. This is demonstrated by our looking at patents for potential vaccines and detection methods, as well as dealing with urgent approval for medical devices and personal protective equipment.
Whatever your background, we can help you commercialize your inventions, protect key intellectual property and structure your business and partnerships to best enable you to bring the next generation of medicines, products and services to market.
Some of our recent work includes:
- representing an US pharmaceutical company in the reorganization of its Austrian distribution organization
- advising a market-leading Austrian home nursing services provider on the organization and the standard agreements for its 24-hour care
- advising in unfair trade litigation regarding advertisement for drugs and medical devices
- advising life sciences companies on all issues of public procurement of medicinal products by hospitals and governmental agencies
- advising a pharmaceutical wholesaler on issues of the verification of the authenticity of medicinal products and related issues of data protection
Latest Публикации
- legal updatesThe EDPB’s new scientific research guidelines: a welcome route map, but no shortcut for “research” by assertion
- legal updatesHong Kong: Open consultation on listing reforms
- legal updates
- legal updates
Latest News
- новини от насEversheds Sutherland Advises The Centurion Foundation on Completed Acquisition of Roger Williams Medical Center and Fatima Hospital
- новини от клиентиEversheds Sutherland advises on £5.2bn disposal of Barchester Healthcare
- новини от клиентиEversheds Sutherland advises Edwards Lifesciences on its US$4.2bn sale of Critical Care
- новини от насEversheds Sutherland continues IP and Life Sciences practice expansion with European lateral partner hire
новини от нас
20 март 2026 г.
Eversheds Sutherland Advises The Centurion Foundation on Completed Acquisit...
новини от клиенти
06 ноември 2025 г.
Eversheds Sutherland advises on £5.2bn disposal of Barchester Healthcare
новини от клиенти
06 септември 2024 г.
Eversheds Sutherland advises Edwards Lifesciences on its US$4.2bn sale of C...
новини от нас
03 ноември 2022 г.
Eversheds Sutherland continues IP and Life Sciences practice expansion with...